The question in the headline is practical, not rhetorical
There's only one idea more revolutionary than weight loss drugs from lizard spit, and that is supporting our show on Patreon
Retatrutide may be appropriate for patients with significant obesity, particularly those who have plateaued on GLP-1 or dual-agonist therapies, or those with concurrent metabolic concerns such as elevated liver fat or poor lipid profiles
In our study, nausea, vomiting, or constipation were reported at slightly higher rates
The correlation between delayed gastric emptying and GLP-1 RAs raises concerns about the possible negative effects in the periprocedural setting, as evidenced by case reports of aspiration events occurring during procedural anesthesia in patients administered GLP-1 RAs [14,15]